Search International and National Patent Collections
|1. (WO2018036941) COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND A NUCLEOS(T)IDE ANALOGUE|
|Applicants:||F. HOFFMANN-LA ROCHE AG
HOFFMANN-LA ROCHE INC.
|Title:||COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND A NUCLEOS(T)IDE ANALOGUE|
The present invention is directed to compositions and uses thereof for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of an HBV capsid assembly inhibitor and a nucleoside or nucleotide analogue for use in the treatment or prophylaxis of chronic hepatitis B patient.